Blood filtration market seen reaching $7.12 billion by 2030

The Business Research Company says the global blood filtration and purification market will grow from $4.83 billion in 2026 to $7.12 billion by 2030, driven by rising blood-related disorders, more diagnostic spending and adoption of automated systems. North America led in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Blood filtration and purification is used to remove toxins, excess fluids and other harmful substances from blood. - Demand is rising as healthcare systems face more infectious and chronic diseases, more blood-related disorders and broader use in clinical diagnostics. - The market outlook points to continued investment in filtration devices, membranes, kits and lab automation.

What happened: - The Business Research Company released a 2026 market report on the global blood filtration and purification market. - The report puts the market at $4.83 billion in 2026, up from $4.38 billion in 2025. - The report forecasts the market will reach $7.12 billion by 2030. - The forecast implies a 10.2% CAGR from 2026 to 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company is offering a free sample of the report. - The company is also offering the full market report.

The details: - The report says recent growth has been driven by continued use of manual blood purification techniques. - Limited access to advanced filtration membranes has also supported demand. - Rising infectious and chronic disease cases have added to market growth. - Expansion in hospital and clinical laboratory infrastructure has contributed to the market. - Traditional sample preparation methods remain in use and continue to support demand. - The report says growth through 2030 will come from automated, high-throughput filtration systems. - Research in genetic and molecular diagnostics is expected to increase demand. - Clinical diagnostic laboratories are drawing more investment. - Demand is rising for disposable and specialized blood filtration kits. - Improvements in membrane and assay design are expected to support adoption. - Expected trends include broader use of automated filtration devices. - The report also points to stronger demand for disposable filtration reagents and kits. - Specialty assays and filtration columns are gaining more use in diagnostics. - Membranes and consumables are expected to expand as a segment. - The market is increasingly focused on improving sample preparation and purification efficiency. - Blood filtration and purification is described as a therapeutic process that cleans blood outside the body before returning it to the patient. - The treatment is used to support compromised organ function, combat infections and maintain physiological balance in critically ill patients. - Rising blood-related disorders are a major driver, helped by an aging global population. - The American Society of Hematology projected in November 2024 that new leukemia cases in the United States will reach 519,540 by 2050. - The report says healthcare infrastructure expansion, more awareness of advanced diagnostic methods and technology improvements are also contributing to growth. - The 2026 report includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Between the lines: - The forecast suggests blood filtration is shifting from a largely manual, infrastructure-constrained market toward a more automated diagnostics and lab-tech category. - Faster growth in Asia-Pacific points to a broader buildout of healthcare capacity outside North America. - Demand for disposable kits and consumables signals recurring revenue opportunities, not just one-time equipment sales.

What's next: - The market is expected to keep expanding as hospitals and diagnostic labs adopt more automated filtration systems. - Investment should continue to follow genetic and molecular testing, where sample preparation quality matters more. - The next competition point is likely to be efficiency, throughput and membrane performance rather than basic access alone.

The bottom line: - Blood filtration and purification is moving into a faster-growth phase, with automation, diagnostics and disease prevalence driving the next leg of expansion.